Kisspeptin-54 (Metastin) — Indexed Studies

Impact of lipodystrophy syndrome on the quality of life of patients receiving antiretroviral treatment: is this a solved question or a recurring problem?

Oliveira JC, Macedo NF, Mayitondelua N et al.

Facelift as a novel surgical treatment for HIV-associated facial lipodystrophy: a case report and literature review.

Ashraf D, Shah R, Tomouk T et al.

Comorbidities in people living with HIV/AIDS and their impact on outpatient dental care.

Bartholo MF, Tenório JR, Andrade NS et al.

Current status and perspectives in the treatment of facial lipoatrophy in HIV-positive patients in 2024.

Tilhet L, Rouanet M, Henry AS et al.

Serum Leucine-Rich Alpha-2 Glycoprotein 1 Levels in Patients with Lipodystrophy Syndromes.

Krienke M, Kralisch S, Wagner L et al.

Evidence from clinical studies of leptin: current and future clinical applications in humans.

Perakakis N, Mantzoros CS

Correlation of APOE polymorphism, expression, and plasma levels with cardiac comorbidities among lipodystrophy in HIV-infected patients.

Shyamveer, Antony Jenitha A, Bhattacharya M et al.

Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial.

Eckard AR, Wu Q, Sattar A et al.

Role of APOC3 3238C/G, APOB 12669G/A and SCARB1 1050C/T polymorphisms, their expression in patients of HIV-associated lipodystrophy.

Singh H, Shyamveer, Jori C et al.

Biological Depiction of Lipodystrophy and Its Associated Challenges Among HIV AIDS Patients: Literature Review.

Lamesa TA

Determinants of Metabolic Syndrome Among Patients Receiving Anti-Retro-Viral Treatment in A Tertiary Hospital, Central Ethiopia: Unmatched Case-Control Study.

Jarso G, Aman H, Megerso A

A retrospective study on side effects of first-line antiretroviral drugs on HIV patients based on 1A, 2A, and 5A regimen records at Zomba Central Hospital, Malawi.

Sindie R, Mwakilama E, Chizala P et al.

Isolated collagenoma in an HIV-positive patient on ART: a case report.

Wu KK, Movassaghi M, DeClerck B et al.

Use of Intralesional Deoxycholic Acid for Antiretroviral Treatment Associated Lipohypertrophy: A Qualitative Open-Label Study of an Innovative Indication.

Kulkarni V, Salunke TS, Mandhane AG et al.

Comparative analysis of MTP -493G/T and ABCG2 34G/A polymorphisms and theirs expression in HIV-associated lipodystrophy patients.

Singh H, Jori C, Shyamveer et al.

Patients living with HIV have quantitatively inadequate food consumption.

Vercesi BF, Moscardini IS, Esteves GP et al.

Weight gain in HIV-infected patients.

Rodríguez AP, Lillo IS, González CS et al.

Antiretroviral therapy regimen modification rates and associated factors in a cohort of HIV/AIDS patients in Asmara, Eritrea: a 16-year retrospective analysis.

Mengistu ST, Yohannes A, Issaias H et al.

REVERSIBILITY OF LIPOATROPHY IN HIV-INFECTED PATIENTS TAKING ANTIRETROVIRAL THERAPY: A COHORT STUDY WITH ULTRASOUND ASSESSMENT.

Šoštarić Zadro A, Višković K, Begovac J

Nutritional aberration and related morphological disorders among patients with human immunodeficiency virus infection on combination antiretroviral therapy (cART) in Ghana: A retrospective study.

Agordoh PD, Lokpo SY, Owiredu WKBA et al.

Relationship between phase angle, steatosis, and liver fibrosis in patients coinfected with human immunodeficiency virus/hepatitis C virus.

Fernandes SA, Tovo CV, da Silva ALM et al.

PCSK9 and ANGPTL3 levels correlate with hyperlipidemia in HIV-lipoatrophy, are regulated by fasting and are not affected by leptin administered in physiologic or pharmacologic doses.

Bouzoni E, Perakakis N, Connelly MA et al.

Synergic effect of metabolic syndrome and lipodystrophy on oxidative stress and inflammation process in treated HIV-patients.

González-Domenech CM, Plaza-Andrades IJ, Garrido-Sanchez L et al.

Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study.

Lemoine M, Assoumou L, Girard PM et al.

Genetic and cytometric analyses of subcutaneous adipose tissue in patients with hemophilia and HIV-associated lipodystrophy.

Mashiko T, Tsukada K, Takada H et al.

Approach to the Patient With Lipodystrophy.

Fourman LT, Grinspoon SK

Consideration of Human Immunodeficiency Status in Patients Seeking Facial Feminization Surgery.

Rodriguez Colon R, Chaya BF, Berman ZP et al.

Experiences and Perspectives of Patients with Non-HIV-Associated Lipodystrophies and Their Caregivers: A Qualitative Study.

Gomes A, Cook K, Wong A et al.

Adipocytokine dysregulation, abnormal glucose metabolism, and lipodystrophy in HIV-infected adolescents receiving protease inhibitors.

Santiprabhob J, Chokephaibulkit K, Khantee P et al.

Coronary artery disease in patients with human immunodeficiency virus infection.

Mondal P, Aljizeeri A, Small G et al.

The HIV Outpatient Study-25 Years of HIV Patient Care and Epidemiologic Research.

Buchacz K, Armon C, Palella FJ Jr et al.

Estimating HIV Management and Comorbidity Costs Among Aging HIV Patients in the United States: A Systematic Review.

Ward T, Sugrue D, Hayward O et al.

Biological Features Implies Potential Use of Autologous Adipose-Derived Stem/Progenitor Cells in Wound Repair and Regenerations for the Patients with Lipodystrophy.

Suzuki K, Akita S, Yoshimoto H et al.

Liver enzyme elevation in patients taking HAART compared with treatment naïve controls at Debre Berhan Referral Hospital: a comparative cross-sectional study, Northeast Ethiopia.

Tesfa E, Siefu D, Belayneh Y et al.

Association between lipodystrophy and length of exposure to ARTs in adult HIV-1 infected patients in Montreal.

Alikhani A, Morin H, Matte S et al.

Subcutaneous Adipocyte Adenosine Triphosphate Levels in HIV Infected Patients.

Gojanovich GS, Shikuma CM, Milne C et al.

Total thyroidectomy in HIV positive patient with buffalo hump and taurine neck.

Carrese E, Morandi U, Stefani A et al.

CT Fat Density Accurately Reflects Histologic Fat Quality in Adults With HIV On and Off Antiretroviral Therapy.

Lake JE, Moser C, Johnston L et al.

Comorbidities and Survival in Patients With Lipodystrophy: An International Chart Review Study.

Akinci B, Oral EA, Neidert A et al.

Psychopathological and psychiatric evaluation of patients affected by lipodystrophy.

Calabrò PF, Ceccarini G, Calderone A et al.

Natural Course of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Patients With Human Immunodeficiency Virus With and Without Combination Antiretroviral Therapy-associated Lipodystrophy: A 16-Year Follow-up Study.

Lallukka-Brück S, Isokuortti E, Luukkonen PK et al.

MRI Assessment of Treatment Response in HIV-associated NAFLD: A Randomized Trial of a Stearoyl-Coenzyme-A-Desaturase-1 Inhibitor (ARRIVE Trial).

Ajmera VH, Cachay E, Ramers C et al.

Ten-Year and Beyond Follow-up After Treatment With Highly Purified Liquid-Injectable Silicone for HIV-Associated Facial Lipoatrophy: A Report of 164 Patients.

Jones DH, Carruthers A, Brody HJ et al.

Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial.

Venter WDF, Kambugu A, Chersich MF et al.

Prediction of Cardiovascular Disease Risk Using Framingham and Data on Adverse Effect of Antiretroviral Drugs Risk Equation in Relation to Lipodystrophy in HIV Patients on Highly Active Antiretroviral Therapy.

Kumar D, Bohra GK, Agarwal M et al.

Fat Mass Ratio in Brazilian HIV-infected Patients Under Antiretroviral Therapy and Its Relationship With Anthropometric Measurents.

Bicudo Bruno Nogueira A, Abreu JM, Mesquita Villela M et al.

Association of raltegravir use with long-term health outcomes in HIV-infected patients: an observational post-licensure safety study in a large integrated healthcare system.

Horberg MA, Oakes AH, Hurley LB et al.

Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID Study.

Bouatou Y, Gayet Ageron A, Bernasconi E et al.

Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test - which method to choose for the diagnosis?

Coelho AR, Moreira FA, Santos AC et al.

Effect of combined training on body composition and metabolic variables in people living with HIV: A randomized clinical trial.

Guariglia DA, Pedro RE, Deminice R et al.

Histological and Molecular Adipose Tissue Changes Are Related to Metabolic Syndrome Rather Than Lipodystrophy in Human Immunodeficiency Virus-Infected Patients: A Cross-Sectional Study.

Langkilde A, Tavenier J, Danielsen AV et al.